Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Penson

Showing results (381-390 of 570) with videos related to

Pageof 57
Sort By:
Journal of General Internal Medicine|December 3, 2014
Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiariesJeffrey C Bassett, JoAnn Alvarez, Tatsuki Koyama, et al.
The American Journal of Managed Care|November 29, 2017
The influence of provider characteristics and market forces on response to financial incentivesBrock O'Neil, Mark Tyson, Amy J Graves, et al.
Journal of the National Cancer Institute|July 4, 2002
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trendsRuth Etzioni, David F Penson, Julie M Legler, et al.
The Journal of Urology|June 19, 2015
Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United StatesDaniel A Barocas, Katherine Mallin, Amy J Graves, et al.
Cancer|March 29, 2006
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancerSteven B Zeliadt, Scott D Ramsey, David F Penson, et al.
The Journal of Urology|May 30, 2017
Recent Changes in Prostate Cancer Screening Practices and EpidemiologyDaniel J Lee, Katherine Mallin, Amy J Graves, et al.
Journal of Robotic Surgery|February 2, 2021
The prevention of extraction site incisional hernia after robotic-assisted radical prostatectomyDavid P Feng, Amy N Luckenbaugh, Zuliang Feng, et al.
Urology|July 31, 2013
Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysisHuei-Ting Tsai, David F Penson, Kepher H Makambi, et al.
JAMA Surgery|September 23, 2016
Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate CancerMark D Tyson, Amy J Graves, Brock O'Neil, et al.
BJU International|January 13, 2011
Long-term outcome in patients with a Gleason score ≤ 6 prostate cancer treated by radical prostatectomyMarc Birkhahn, David F Penson, Jie Cai, et al.
Pageof 57

Showing results (381-390 of 570) with videos related to

Sort By:
Pageof 57
Journal of General Internal Medicine|December 3, 2014
Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiariesJeffrey C Bassett, JoAnn Alvarez, Tatsuki Koyama, et al.
The American Journal of Managed Care|November 29, 2017
The influence of provider characteristics and market forces on response to financial incentivesBrock O'Neil, Mark Tyson, Amy J Graves, et al.
Journal of the National Cancer Institute|July 4, 2002
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trendsRuth Etzioni, David F Penson, Julie M Legler, et al.
The Journal of Urology|June 19, 2015
Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United StatesDaniel A Barocas, Katherine Mallin, Amy J Graves, et al.
Cancer|March 29, 2006
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancerSteven B Zeliadt, Scott D Ramsey, David F Penson, et al.
The Journal of Urology|May 30, 2017
Recent Changes in Prostate Cancer Screening Practices and EpidemiologyDaniel J Lee, Katherine Mallin, Amy J Graves, et al.
Journal of Robotic Surgery|February 2, 2021
The prevention of extraction site incisional hernia after robotic-assisted radical prostatectomyDavid P Feng, Amy N Luckenbaugh, Zuliang Feng, et al.
Urology|July 31, 2013
Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysisHuei-Ting Tsai, David F Penson, Kepher H Makambi, et al.
JAMA Surgery|September 23, 2016
Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate CancerMark D Tyson, Amy J Graves, Brock O'Neil, et al.
BJU International|January 13, 2011
Long-term outcome in patients with a Gleason score ≤ 6 prostate cancer treated by radical prostatectomyMarc Birkhahn, David F Penson, Jie Cai, et al.
Pageof 57